{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:51:45Z","timestamp":1785228705169,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accumulating evidence suggests that placenta-specific 8 (PLAC8) plays an important role in normal cellular process and human diseases, including multiple types of human tumors, and its role is highly relied upon in cellular and physiologic contexts. However, there are no reports on its expression profile and biological roles during lung cancer development. In the current study, both the clinical implications and biological effects of PLAC8 in lung cancer (LC) progression were investigated, and we identified and described the novel Kru\u0308ppel-like factor 4 (KLF4)\/PLAC8 regulatory pathway in cancer progression. Elevated PLAC8 levels were positively correlated with tumor size, histological grade, and tumor node metasis (TNM) stage, and LC patients with high PLAC8 expression suffered poor outcomes. In vitro and in vivo assays further revealed that endogenous PLAC8 promoted cell proliferation and tumor formation. We also found downregulated PLAC8 protein in several LC cell lines following the induction of KLF4, and immunohistochemistry analysis of LC tissues by microarray indicated a potential inverse correlation between PLAC8 and KLF4 expression. Luciferase reporter analysis and chromatin immunoprecipitation assays determined that KLF4 negatively regulated PLAC8 promoter activity via directly binding to the promoter region. Furthermore, the growth inhibition resulting from KLF4 overexpression was partially rescued by ectopic PLAC8 expression. Together, our data uncovered a previously unidentified role of PLAC8 as a central mediator in LC progression. PLAC8 was transcriptionally repressed by KLF4, and the novel KLF4\/PLAC8 axis may act as a promising candidate target for LC diagnosis and therapy.<\/jats:p>","DOI":"10.1038\/s41419-018-0580-3","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T14:54:58Z","timestamp":1527000898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The novel KLF4\/PLAC8 signaling pathway regulates lung cancer growth"],"prefix":"10.1038","volume":"9","author":[{"given":"Yunlu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"580_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"580_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7\u201330 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"580_CR3","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1073\/pnas.97.16.9127","volume":"97","author":"TS Tanaka","year":"2000","unstructured":"Tanaka, T. S. et al. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc. Natl. Acad. Sci. USA 97, 9127\u20139132 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"580_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0378-1119(03)00508-0","volume":"309","author":"C Galaviz-Hernandez","year":"2003","unstructured":"Galaviz-Hernandez, C. et al. Plac8 and Plac9, novel placental-enriched genes identified through microarray analysis. Gene 309, 81 (2003).","journal-title":"Gene"},{"key":"580_CR5","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1038\/sj.onc.1208897","volume":"24","author":"K Rogulski","year":"2005","unstructured":"Rogulski, K. et al. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene 24, 7524 (2005).","journal-title":"Oncogene"},{"key":"580_CR6","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.4049\/jimmunol.178.8.5132","volume":"178","author":"JG Ledford","year":"2007","unstructured":"Ledford, J. G., Kovarova, M. & Koller, B. H. Impaired host defense in mice lacking ONZIN. J. Immunol. 178, 5132\u20135143 (2007).","journal-title":"J. Immunol."},{"key":"580_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmet.2011.08.008","volume":"14","author":"M Jimenez-Preitner","year":"2011","unstructured":"Jimenez-Preitner, M. et al. Plac8 is an inducer of C\/EBP\u03b2 required for brown fat differentiation, thermoregulation, and control of body weight. Cell Metab. 14, 658\u2013670 (2011).","journal-title":"Cell Metab."},{"key":"580_CR8","doi-asserted-by":"publisher","first-page":"e48767","DOI":"10.1371\/journal.pone.0048767","volume":"7","author":"JP Maria","year":"2012","unstructured":"Maria, J. P., Xavier, B. & Bernard, T. Plac8 is required for white adipocyte differentiation in vitro and cell number control in vivo. PLoS ONE 7, e48767 (2012).","journal-title":"PLoS ONE"},{"key":"580_CR9","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.4049\/jimmunol.1102764","volume":"188","author":"RM Johnson","year":"2012","unstructured":"Johnson, R. M., Kerr, M. S. & Slaven, J. E. Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J. Immunol. 188, 1896\u20131904 (2012).","journal-title":"J. Immunol."},{"key":"580_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3892\/ijo.2013.1954","volume":"43","author":"H Uehara","year":"2013","unstructured":"Uehara, H., Takahashi, T. & Izumi, K. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. Int. J. Oncol. 43, 365 (2013).","journal-title":"Int. J. Oncol."},{"key":"580_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.celrep.2014.03.061","volume":"7","author":"C Kinsey","year":"2014","unstructured":"Kinsey, C. et al. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep. 7, 1143 (2014).","journal-title":"Cell Rep."},{"key":"580_CR12","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1172\/JCI71103","volume":"124","author":"C Li","year":"2014","unstructured":"Li, C. et al. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J. Clin. Invest. 124, 2172\u20132187 (2014).","journal-title":"J. Clin. Invest."},{"key":"580_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-6-97","volume":"6","author":"LR Grate","year":"2005","unstructured":"Grate, L. R. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery. BMC Bioinform. 6, 1\u201316 (2005).","journal-title":"BMC Bioinform."},{"key":"580_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopha.2016.09.015","volume":"84","author":"L Zou","year":"2016","unstructured":"Zou, L. et al. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K\/Akt\/GSK3beta\/Wnt\/beta-catenin signaling. Biomed. Pharmacother. 84, 139\u2013146 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"580_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s11255-017-1578-y","volume":"49","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Int. Urol. Nephrol. 49, 1165\u20131176 (2017).","journal-title":"Int. Urol. Nephrol."},{"key":"580_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ncb1698","volume":"10","author":"J Jiang","year":"2008","unstructured":"Jiang, J. et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10, 353\u2013360 (2008).","journal-title":"Nat. Cell Biol."},{"key":"580_CR17","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1074\/jbc.271.33.20009","volume":"271","author":"JM Shields","year":"1996","unstructured":"Shields, J. M., Christy, R. J. & Yang, V. W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem. 271, 20009\u201320017 (1996).","journal-title":"J. Biol. Chem."},{"key":"580_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/11926","volume":"22","author":"JA Segre","year":"1999","unstructured":"Segre, J. A., Bauer, C. & Fuchs, E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22, 356\u2013360 (1999).","journal-title":"Nat. Genet."},{"key":"580_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"580_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2008.10.004","volume":"3","author":"Y Shi","year":"2008","unstructured":"Shi, Y. et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568\u2013574 (2008).","journal-title":"Cell Stem Cell"},{"key":"580_CR21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc3582","volume":"13","author":"MP Tetreault","year":"2013","unstructured":"Tetreault, M. P., Yang, Y. & Katz, J. P. Kr\u00fcppel-like factors in cancer. Nat. Rev. Cancer 13, 701 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"580_CR22","first-page":"3577","volume":"69","author":"W Hu","year":"2009","unstructured":"Hu, W. He, C. Fang, B. & Swisher, S. G. Abstract #3577: putative tumor-suppressor function of Kr\u00fcppel-like lactor 4 in primary lung carcinoma. Cancer Res. 69, 3577 (2009).","journal-title":"Cancer Res."},{"key":"580_CR23","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1002\/cncr.26698","volume":"118","author":"WT Yang","year":"2012","unstructured":"Yang, W. T. & Zheng, P. S. Kruppel-like factor 4 functions as a tumor suppressor in cervical carcinoma. Cancer 118, 3691\u20133702 (2012).","journal-title":"Cancer"},{"key":"580_CR24","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-04-3619","volume":"65","author":"D Wei","year":"2005","unstructured":"Wei, D. et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 65, 2746\u20132754 (2005).","journal-title":"Cancer Res."},{"key":"580_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.02.005","volume":"29","author":"D Wei","year":"2016","unstructured":"Wei, D. et al. KLF4 is essential for induction of cellular identity change and acinar-to-ductal reprograming during early pancreatic carcinogenesis. Cancer Cell 29, 324 (2016).","journal-title":"Cancer Cell"},{"key":"580_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jmcb\/mjx023","volume":"9","author":"H Tang","year":"2017","unstructured":"Tang, H. et al. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. J. Mol. Cell. Biol. 9, 315\u2013324 (2017).","journal-title":"J. Mol. Cell. Biol."},{"key":"580_CR27","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.4161\/cbt.4.12.2355","volume":"4","author":"CC Huang","year":"2005","unstructured":"Huang, C. C. et al. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol. Ther. 4, 1401 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"580_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4161\/cbt.7.5.5768","volume":"7","author":"YJ Chen","year":"2008","unstructured":"Chen, Y. J. et al. Nuclear Kr\u00fcppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol. Ther. 7, 777\u2013782 (2008).","journal-title":"Cancer Biol. Ther."},{"key":"580_CR29","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1038\/onc.2016.481","volume":"36","author":"M Riverso","year":"2017","unstructured":"Riverso, M., Montagnani, V. & Stecca, B. KLF4 is regulated by RAS\/RAF\/MEK\/ERK signaling through E2F1 and promotes melanoma cell growth. Oncogene 36, 3322\u20133333 (2017).","journal-title":"Oncogene"},{"key":"580_CR30","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm.4400","volume":"23","author":"M Murgai","year":"2017","unstructured":"Murgai, M. et al. KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nat. Med. 23, 1176\u20131190 (2017).","journal-title":"Nat. Med."},{"key":"580_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1158\/1078-0432.CCR-16-1064","volume":"23","author":"K Guo","year":"2017","unstructured":"Guo, K. et al. A novel KLF4-MSI2 signaling pathway regulates growth and metastasis of pancreatic cancer. Clin. Cancer Res.\n                           23, 687\u2013696 (2017).","journal-title":"Clin. Cancer Res."},{"key":"580_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/nar\/28.5.1106","volume":"28","author":"DE Geiman","year":"2000","unstructured":"Geiman, D. E., Han, T. T., Johnson, J. M. & Yang, V. W. Transactivation and growth suppression by the gut-enriched Kr\u00fcppel-like factor (Kr\u00fcppel-like factor 4) are dependent on acidic amino acid residues and protein\u2013protein interaction. Nucleic Acids Res. 28, 1106\u20131113 (2000).","journal-title":"Nucleic Acids Res."},{"key":"580_CR33","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1074\/jbc.273.2.1026","volume":"273","author":"SF Yet","year":"1998","unstructured":"Yet, S. F. et al. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem. 273, 1026 (1998).","journal-title":"J. Biol. Chem."},{"key":"580_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4161\/cbt.9.7.11106","volume":"9","author":"Y Zhou","year":"2010","unstructured":"Zhou, Y. et al. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol. Ther. 9, 507\u2013513 (2010).","journal-title":"Cancer Biol. Ther."},{"key":"580_CR35","doi-asserted-by":"crossref","first-page":"52870","DOI":"10.18632\/oncotarget.9141","volume":"7","author":"W Hu","year":"2016","unstructured":"Hu, W. et al. KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth. Oncotarget 7, 52870\u201352887 (2016).","journal-title":"Oncotarget"},{"key":"580_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.molcel.2011.11.031","volume":"45","author":"AM Gamper","year":"2012","unstructured":"Gamper, A. M. et al. Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis. Mol. Cell 45, 233\u2013243 (2012).","journal-title":"Mol. Cell"},{"key":"580_CR37","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1158\/1078-0432.CCR-09-0310","volume":"15","author":"W Hu","year":"2009","unstructured":"Hu, W. et al. Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin. Cancer Res. 15, 5688\u20135695 (2009).","journal-title":"Clin. Cancer Res."},{"key":"580_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopha.2016.09.015","volume":"84","author":"L Zou","year":"2016","unstructured":"Zou, L. et al. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K\/Akt\/GSK3\u03b2\/Wnt\/\u03b2-catenin signaling. Biomed. Pharmacother. 84, 139\u2013146 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"580_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11255-017-1578-y","volume":"49","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma. Int. Urol. Nephrol. 49, 1\u201312 (2017).","journal-title":"Int. Urol. Nephrol."},{"key":"580_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/0008-5472.CAN-15-0216","volume":"76","author":"BP Kaistha","year":"2016","unstructured":"Kaistha, B. P. et al. PLAC8 localizes to the inner plasma membrane of pancreatic cancer cells and regulates cell growth and disease progression through critical cell-cycle regulatory pathways. Cancer Res. 76, 96\u2013107 (2016).","journal-title":"Cancer Res."},{"key":"580_CR41","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1172\/JCI71103","volume":"124","author":"C Li","year":"2014","unstructured":"Li, C. et al. Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. J. Clin. Invest. 124, 2172 (2014).","journal-title":"J. Clin. Invest."},{"key":"580_CR42","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1038\/sj.onc.1208897","volume":"24","author":"K Rogulski","year":"2005","unstructured":"Rogulski, K. et al. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway. Oncogene 24, 7524\u20137541 (2005).","journal-title":"Oncogene"},{"key":"580_CR43","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/leu.2009.280","volume":"24","author":"SF Wu","year":"2010","unstructured":"Wu, S. F. et al. The downregulation of onzin expression by PKCepsilon-ERK2 signaling and its potential role in AML cell differentiation. Leukemia 24, 544 (2010).","journal-title":"Leukemia"},{"key":"580_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2174\/156800913804486584","volume":"13","author":"M Mourtadamaarabouni","year":"2013","unstructured":"Mourtadamaarabouni, M., Watson, D., Munir, M., Farzaneh, F. & Williams, G. T. Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types. Curr. Cancer Drug Targets 13, 80 (2013).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"Suppl. C","key":"580_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopha.2016.09.015","volume":"84","author":"L Zou","year":"2016","unstructured":"Zou, L. et al. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K\/Akt\/GSK3\u03b2\/Wnt\/\u03b2-catenin signaling. Biomed. Pharmacother. 84(Suppl. C), 139\u2013146 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"580_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/0008-5472.CAN-15-0216","volume":"76","author":"BP Kaistha","year":"2015","unstructured":"Kaistha, B. P. et al. PLAC8 localizes to the inner plasma membrane of pancreatic cancer cells and regulates cell growth and disease progression through critical cell-cycle regulatory pathways. Cancer Res. 76, 96 (2015).","journal-title":"Cancer Res."},{"issue":"Suppl. C","key":"580_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.canlet.2017.08.023","volume":"408","author":"V Kolluru","year":"2017","unstructured":"Kolluru, V. et al. Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis. Cancer Lett. 408(Suppl. C), 121\u2013129 (2017).","journal-title":"Cancer Lett."},{"key":"580_CR48","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nature06973","volume":"453","author":"HR McMurray","year":"2008","unstructured":"McMurray, H. R. et al. Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature 453, 1112 (2008).","journal-title":"Nature"},{"key":"580_CR49","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1242\/dev.129.11.2619","volume":"129","author":"JP Katz","year":"2002","unstructured":"Katz, J. P. et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 2619\u20132628 (2002).","journal-title":"Development"},{"key":"580_CR50","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1038\/sj.emboj.7601824","volume":"26","author":"MW Feinberg","year":"2007","unstructured":"Feinberg, M. W. et al. The Kruppel\u2010like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138\u20134148 (2007).","journal-title":"EMBO J."},{"key":"580_CR51","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4161\/cbt.4.11.2090","volume":"4","author":"Y Yang","year":"2005","unstructured":"Yang, Y., Goldstein, B. G., Chao, H. H. & Katz, J. P. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther. 4, 1216\u20131221 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"580_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1780","volume":"6","author":"BD Rowland","year":"2006","unstructured":"Rowland, B. D. & Peeper, D. S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 6, 11 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"580_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.molonc.2012.12.002","volume":"7","author":"N Mohan","year":"2013","unstructured":"Mohan, N., Ai, W., Chakrabarti, M., Banik, N. L. & Ray, S. K. KLF4 overexpression and apigenin treatment down regulated anti\u2010apoptotic Bcl\u20102 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK\u2010N\u2010DZ and IMR\u201032 cells. Mol. Oncol. 7, 464\u2013474 (2013).","journal-title":"Mol. Oncol."},{"key":"580_CR54","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1002\/cncr.26698","volume":"118","author":"WT Yang","year":"2012","unstructured":"Yang, W. T. Kr\u00fcppel-like factor 4 functions as a tumor suppressor in cervical carcinoma. Cancer 118, 3691\u20133702 (2012).","journal-title":"Cancer"},{"key":"580_CR55","doi-asserted-by":"publisher","first-page":"e43593","DOI":"10.1371\/journal.pone.0043593","volume":"7","author":"ZS Lin","year":"2012","unstructured":"Lin, Z. S., Chu, H. C., Yen, Y. C., Lewis, B. C. & Chen, Y. W. Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS ONE 7, e43593 (2012).","journal-title":"PLoS ONE"},{"key":"580_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ajpath.2010.11.021","volume":"178","author":"F Zammarchi","year":"2011","unstructured":"Zammarchi, F. et al. KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am. J. Pathol. 178, 361 (2011).","journal-title":"Am. J. Pathol."},{"key":"580_CR57","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1182\/blood-2009-12-256446","volume":"116","author":"H Guan","year":"2010","unstructured":"Guan, H. et al. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood 116, 1469 (2010).","journal-title":"Blood"},{"key":"580_CR58","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1038\/onc.2010.591","volume":"30","author":"F Yu","year":"2011","unstructured":"Yu, F. et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30, 2161\u20132172 (2011).","journal-title":"Oncogene"},{"key":"580_CR59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1593\/neo.11260","volume":"13","author":"JL Yori","year":"2011","unstructured":"Yori, J. L. et al. Kr\u00fcppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 13, 601 (2011).","journal-title":"Neoplasia"},{"key":"580_CR60","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1038\/onc.2009.151","volume":"28","author":"K Akaogi","year":"2009","unstructured":"Akaogi, K. et al. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER[alpha]. Oncogene 28, 2894\u20132902 (2009).","journal-title":"Oncogene"},{"key":"580_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cellsig.2017.09.025","volume":"42","author":"Y Jia","year":"2017","unstructured":"Jia, Y. et al. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer. Cell Signal. 42, 165\u2013175 (2017).","journal-title":"Cell Signal."},{"key":"580_CR62","doi-asserted-by":"publisher","first-page":"18391","DOI":"10.1074\/jbc.C000062200","volume":"275","author":"W Zhang","year":"2000","unstructured":"Zhang, W. et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1\/Cip1 promoter. J. Biol. Chem. 275, 18391\u201318398 (2000).","journal-title":"J. Biol. Chem."},{"key":"580_CR63","doi-asserted-by":"publisher","first-page":"C1175","DOI":"10.1152\/ajpcell.00288.2008","volume":"295","author":"T Yoshida","year":"2008","unstructured":"Yoshida, T., Gan, Q. & Owens, G. K. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 295, C1175\u2013C1182 (2008).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"580_CR64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/cdd.2015.85","volume":"23","author":"T Yu","year":"2016","unstructured":"Yu, T. et al. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 23, 207\u2013215 (2016).","journal-title":"Cell Death Differ."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0580-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0580-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0580-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:56:48Z","timestamp":1671537408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0580-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":64,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0580-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"24 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"603"}}